Synthego was a Redwood City CRISPR-tools company supplying synthetic guide RNA and engineered cells plus the Eclipse automation platform; it filed Chapter 11 in May 2025 and was sold to creditor Perceptive Advisors.
High-throughput cell-line engineering to boost yields for viral-vector and gene-therapy manufacturing.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →